| Institute for Research & Innovation |
Type I Diabetes - Blood Sugar Control
Study Number: 11-END-07Age: 18 yrs or older
Sex: Males and Females
Visits: Patients will have office visits for a maximum of 15 months
Stipend: You will be compensated for your time and travel
Principal Investigator(s): Ronald Graf, MD
Study Coordinator: Shannon Harris, Research Coordinator 253-301-6992
Purpose: To compare the blood sugar control on XXX with insulin glargine after 52 weeks of treatment